相关实验视频
Updated: Jun 9, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
通过与PSMD1的相互作用和增强AR驱动的转录激活,GOLM1促进前列腺癌的进展
Guang Yan1,2, Tianhang Zhu1, Jiawei Zhou1
1Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
戈尔吉膜蛋白1 (GOLM1) 通过增强雄激素受体 (AR) 活性来驱动前列腺癌 (PCa) 的进展. GOLM1与蛋白酶体相互作用,促进AR转录,并为PCa提供潜在的新治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 异常的雄激素受体 (AR) 转录激活是前列腺癌 (PCa) 进展的关键驱动因素.
- 了解调节AR活性的分子机制对于开发有效的PCa疗法至关重要.
研究的目的:
- 研究戈尔吉膜蛋白1 (GOLM1) 在调节前列腺癌中AR驱动的转录活性中的作用.
- 通过确定GOLM1影响AR活性和PCa进展的分子相互作用.
主要方法:
- 对临床和TCGA数据的分析,以将GOLM1表达与AR位基因相关联.
- 质谱和共免疫沉 (Co-IP) 用于识别GOLM1相互作用蛋白.
- 功能性测试,以评估GOLM1对AR转录活性和蛋白酶体功能的影响.
主要成果:
- 在PCa中,GOLM1的表达与AR基因有着强烈的关联.
- GOLM1直接与PSMD1相互作用,PSMD1是26S蛋白酶体的19S调节复合物的组成部分.
- GOLM1增强了全方位蛋白酶的活性,导致AR驱动的转录和PCa进展的增加.
结论:
- 在前列腺癌中,GOLM1作为AR转录活性的关键调节者.
- GOLM1-PSMD1的相互作用增强了蛋白质酶的功能,促进了PCa的进展.
- GOLM1及其相互作用蛋白质代表了AR驱动的前列腺癌的潜在治疗点.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
相关概念视频
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Ras Gene
Ras is a...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity